{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:40:33Z","timestamp":1790181633197,"version":"4.1.0"},"reference-count":36,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"AstraZeneca China"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Respir Dis"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chronic obstructive pulmonary disease (COPD) management in China is inadequate and there is a need to improve care and outcomes for patients nationwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The REAL study was designed to generate reliable information on COPD management from a representative sample of Chinese patients with COPD. Here, we present study outcomes related to acute exacerbations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A 52-week, multicentre, prospective, observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Outpatients (aged\u2009\u2a7e\u200940\u2009years) enrolled from 25 tertiary and 25 secondary hospitals across six geographic regions in China were followed for 12\u2009months. Risk factors for COPD exacerbation and disease severity by exacerbation were assessed using multivariate Poisson and ordinal logistic regression models, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Between June 2017 and January 2019, 5013 patients were enrolled, with 4978 included in the analysis. Mean (standard deviation) age was 66.2 (8.9)\u2009years. More patients presented with exacerbations in secondary versus tertiary hospitals (59.4% versus 40.2%) and in rural versus urban areas (53.2% versus 46.3%). Overall exacerbation rates differed across regions (range: 0.27\u20130.84). Patients from secondary versus tertiary hospitals had higher rates of overall exacerbation (0.66 versus 0.47), severe exacerbation (0.44 versus 0.18) and exacerbation that resulted in hospitalisation (0.41 versus 0.16). Across regions and hospital tiers, the rates of overall exacerbation and exacerbations that resulted in hospitalisation were highest in patients with very severe COPD (based on the severity of airflow limitation or GOLD 2017 combined assessment). Strong predictors of exacerbation included demographic and clinical characteristics, modified Medical Research Council scores, mucus purulence, exacerbation history and the use of maintenance mucolytic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>COPD exacerbation rates varied across regions and were higher in secondary compared with tertiary hospitals in China. Understanding the factors associated with COPD exacerbation may facilitate improved management of COPD exacerbations in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration:<\/jats:title>\n                    <jats:p>The trial was registered on 20 March 2017 (ClinicalTrials.gov: NCT03131362; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03131362 ).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Plain language summary<\/jats:title>\n                    <jats:p>Exacerbations in patients with chronic obstructive pulmonary disease in China Background: Chronic obstructive pulmonary disease (COPD) causes progressive and irreversible airflow limitation. As the disease progresses, patients often experience a flare up of symptoms referred to as an exacerbation. There is inadequate management of COPD in China and, therefore, there is a need to improve care and outcomes for patients across the country. Objective: This study aimed to generate reliable information on exacerbations among Chinese patients with COPD to help inform future management strategies. Study design and methods: Patients (aged\u2009\u2a7e\u200940\u2009years) were enrolled from 25 secondary and 25 tertiary hospitals across six regions of China. Physicians collected data over 1\u2009year during routine outpatient visits. Results: There were more patients who experienced an exacerbation in secondary versus tertiary hospitals (59% versus 40%) and in rural versus urban areas (53% versus 46%). Patients in different geographic regions experienced varying frequencies of exacerbations over 1\u2009year. Compared with patients from tertiary hospitals, patients from secondary hospitals experienced exacerbations (including exacerbations that were severe and those that resulted in hospitalisation) at a higher frequency over 1\u2009year. Patients with very severe disease experienced exacerbations (including exacerbations that resulted in hospitalisation) at the highest frequency over 1\u2009year, regardless of the patient\u2019s geographic region or hospital tier. Patients who had certain characteristics and symptoms, had exacerbation(s) over the previous year, or received medication that aids in the clearance of mucus were more likely to experience exacerbations. Conclusion: The frequency of exacerbations among Chinese patients with COPD varied between patients living in different geographic regions and between patients presenting to different hospital tiers. Understanding the factors related to the occurrence of an exacerbation may help physicians better manage the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17534666231167353","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T05:56:00Z","timestamp":1681883760000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL)"],"prefix":"10.1177","volume":"17","author":[{"given":"Ting","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; National Clinical Research Centre for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiqiang","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; National Clinical Research Centre for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Jian","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease; Guangzhou Institute of Respiratory Disease; National Clinical Research Centre for Respiratory Diseases; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-5435","authenticated-orcid":false,"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, China\u2013Japan Friendship Hospital; National Clinical Research Centre for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Science, No. 2, East Yinghua Road, Chaoyang District, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"bibr1-17534666231167353","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2022 report), https:\/\/goldcopd.org\/wp-content\/uploads\/2021\/12\/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf (2022, accessed 26 August 2022)."},{"key":"bibr2-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30293-X"},{"key":"bibr3-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30427-1"},{"key":"bibr4-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30841-9"},{"key":"bibr5-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200703-456SO"},{"key":"bibr6-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00002610"},{"key":"bibr7-17534666231167353","first-page":"381","volume":"9","author":"Cai BQ","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"bibr8-17534666231167353","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S243595"},{"key":"bibr9-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1177\/17534666231178692"},{"key":"bibr10-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200310-1443OC"},{"key":"bibr11-17534666231167353","first-page":"255","volume":"36","author":"Chinese Society of Respiratory Disease","year":"2013","journal-title":"Chin J Tuberc Respir Dis"},{"key":"bibr12-17534666231167353","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.03.99"},{"key":"bibr13-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02021-w"},{"key":"bibr14-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1177\/17534666231158283"},{"key":"bibr15-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-1000-x"},{"key":"bibr16-17534666231167353","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S36997"},{"key":"bibr17-17534666231167353","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S40437"},{"key":"bibr18-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kww085"},{"key":"bibr19-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00248-2018"},{"key":"bibr20-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909883"},{"key":"bibr21-17534666231167353","volume":"33","author":"Zhang BP","year":"2017","journal-title":"Chin J Hosp Admin"},{"key":"bibr22-17534666231167353","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S175143"},{"key":"bibr23-17534666231167353","volume-title":"Further specifications of the outpatient medical insurance for chronic and special diseases from the Provincial Healthcare Security Administration","author":"Guizhou Province Healthcare Security Administration Document"},{"key":"bibr24-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2017-000267"},{"key":"bibr25-17534666231167353","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6707a1"},{"key":"bibr26-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12525"},{"key":"bibr27-17534666231167353","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17041148"},{"key":"bibr28-17534666231167353","doi-asserted-by":"publisher","DOI":"10.21037\/jxym.2020.02.05"},{"key":"bibr29-17534666231167353","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S276819"},{"key":"bibr30-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07119-3"},{"key":"bibr31-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106725"},{"key":"bibr32-17534666231167353","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S322036"},{"key":"bibr33-17534666231167353","volume":"48","author":"Ismail AI","year":"2016","journal-title":"Eur Respir J"},{"key":"bibr34-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105152"},{"key":"bibr35-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00711-2017"},{"key":"bibr36-17534666231167353","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.10.020"}],"container-title":["Therapeutic Advances in Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666231167353","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17534666231167353","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666231167353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T06:44:40Z","timestamp":1740811480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17534666231167353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":36,"alternative-id":["10.1177\/17534666231167353"],"URL":"https:\/\/doi.org\/10.1177\/17534666231167353","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/17534666231167353\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666231167353\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666231167353\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666231167353\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666231167353\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1753-4666","1753-4666"],"issn-type":[{"value":"1753-4666","type":"print"},{"value":"1753-4666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"article-number":"17534666231167353"}}